DAVID H PERSING Insider Trading $CPHD CEPHEID
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID H PERSING.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID H PERSING. DAVID H PERSING is Director in CEPHEID ($CPHD) and EVP, Chief Med/Tech Officer in CEPHEID ($CPHD) and Exec VP,Chief Med/Tech Officer in CEPHEID ($CPHD).
DAVID H PERSING in CEPHEID
Trading Symbol: CPHDIndustry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of DAVID H PERSING: EVP, Chief Med/Tech Officer, Exec VP,Chief Med/Tech Officer, Director
Holdings: 4,687 shares
Latest Transaction: Feb 02 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID H PERSING in CEPHEID
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 339 | 0 | 3,160 | 2.8 K to 3.2 K (+12.02 %) |
Oct 29 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 302 | 0 | 3,020 | |
Oct 29 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 31.10 | 141 | 4,385 | 2,821 | 3 K to 2.8 K (-4.76 %) |
Oct 29 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 302 | 0 | 2,962 | 2.7 K to 3 K (+11.35 %) |
Jul 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 338 | 0 | 2,370 | |
Jul 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 32.93 | 158 | 5,203 | 2,578 | 2.7 K to 2.6 K (-5.77 %) |
Jul 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 338 | 0 | 2,736 | 2.4 K to 2.7 K (+14.10 %) |
Jul 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 302 | 0 | 3,322 | |
Jul 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 32.51 | 141 | 4,584 | 2,398 | 2.5 K to 2.4 K (-5.55 %) |
Jul 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 302 | 0 | 2,539 | 2.2 K to 2.5 K (+13.50 %) |
Jul 03 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 10,000 | 73,800 | 15,000 | |
Jul 03 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 45.69 | 5,000 | 228,450 | 2,237 | 7.2 K to 2.2 K (-69.09 %) |
Jul 03 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 45.23 | 5,000 | 226,150 | 7,237 | 12.2 K to 7.2 K (-40.86 %) |
Jul 03 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 10,000 | 73,800 | 12,237 | 2.2 K to 12.2 K (+447.03 %) |
Jun 28 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 5,000 | 36,900 | 25,000 | |
Jun 28 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 44.79 | 5,000 | 223,950 | 2,237 | 7.2 K to 2.2 K (-69.09 %) |
Jun 28 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 5,000 | 36,900 | 7,237 | 2.2 K to 7.2 K (+223.51 %) |
May 01 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 339 | 0 | 2,708 | |
May 01 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 38.50 | 159 | 6,122 | 2,237 | 2.4 K to 2.2 K (-6.64 %) |
May 01 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 339 | 0 | 2,396 | 2.1 K to 2.4 K (+16.48 %) |
Apr 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 1,209 | 0 | 3,624 | |
Apr 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 35.72 | 48,750 | 1,741,350 | 48,750 | |
Apr 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 0.00 | 5,417 | 0 | 5,417 | |
Apr 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 37.17 | 565 | 21,001 | 2,057 | 2.6 K to 2.1 K (-21.55 %) |
Apr 26 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 1,209 | 0 | 2,622 | 1.4 K to 2.6 K (+85.56 %) |
Feb 09 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 20,000 | 147,600 | 30,000 | |
Feb 09 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 26,750 | 197,415 | 5,000 | |
Feb 09 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 44.49 | 10,000 | 444,900 | 1,413 | 11.4 K to 1.4 K (-87.62 %) |
Feb 09 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 44.43 | 400 | 17,770 | 11,413 | 11.8 K to 11.4 K (-3.39 %) |
Feb 09 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 43.52 | 9,600 | 417,811 | 11,813 | 21.4 K to 11.8 K (-44.83 %) |
Feb 09 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 43.06 | 26,750 | 1,151,882 | 21,413 | 48.2 K to 21.4 K (-55.54 %) |
Feb 09 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 46,750 | 345,015 | 48,163 | 1.4 K to 48.2 K (+3,308.56 %) |
Jan 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 338 | 0 | 3,047 | |
Jan 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Payment of Exercise | F | 43.14 | 142 | 6,126 | 1,413 | 1.6 K to 1.4 K (-9.13 %) |
Jan 31 2012 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 338 | 0 | 1,555 | 1.2 K to 1.6 K (+27.77 %) |
Nov 01 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 339 | 0 | 3,386 | |
Nov 01 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 338 | 0 | 3,725 | |
Nov 01 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 37.89 | 159 | 6,025 | 1,714 | 1.9 K to 1.7 K (-8.49 %) |
Nov 01 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 339 | 0 | 1,873 | 1.5 K to 1.9 K (+22.10 %) |
Nov 01 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 37.76 | 158 | 5,966 | 1,534 | 1.7 K to 1.5 K (-9.34 %) |
Nov 01 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 338 | 0 | 1,692 | 1.4 K to 1.7 K (+24.96 %) |
Jul 05 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 5,000 | 36,900 | 31,750 | |
Jul 05 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 35.15 | 5,000 | 175,750 | 1,354 | 6.4 K to 1.4 K (-78.69 %) |
Jul 05 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 5,000 | 36,900 | 6,354 | 1.4 K to 6.4 K (+369.28 %) |
Jun 30 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 10,000 | 73,800 | 36,750 | |
Jun 30 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 34.69 | 5,000 | 173,450 | 1,354 | 6.4 K to 1.4 K (-78.69 %) |
Jun 30 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 34.23 | 5,000 | 171,150 | 6,354 | 11.4 K to 6.4 K (-44.04 %) |
Jun 30 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 10,000 | 73,800 | 11,354 | 1.4 K to 11.4 K (+738.55 %) |
Jun 22 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 10,000 | 73,800 | 46,750 | |
Jun 22 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 33.77 | 5,000 | 168,850 | 1,354 | 6.4 K to 1.4 K (-78.69 %) |
Jun 22 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 33.31 | 5,000 | 166,550 | 6,354 | 11.4 K to 6.4 K (-44.04 %) |
Jun 22 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 10,000 | 73,800 | 11,354 | 1.4 K to 11.4 K (+738.55 %) |
Jun 21 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 4,715 | 34,797 | 56,750 | |
Jun 21 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 32.85 | 4,715 | 154,888 | 1,354 | 6.1 K to 1.4 K (-77.69 %) |
Jun 21 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 4,715 | 34,797 | 6,069 | 1.4 K to 6.1 K (+348.23 %) |
Jun 16 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 285 | 2,103 | 61,465 | |
Jun 16 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 32.85 | 285 | 9,362 | 1,354 | 1.6 K to 1.4 K (-17.39 %) |
Jun 16 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 285 | 2,103 | 1,639 | 1.4 K to 1.6 K (+21.05 %) |
Jun 02 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 5,000 | 36,900 | 61,750 | |
Jun 02 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 32.39 | 5,000 | 161,950 | 1,354 | 6.4 K to 1.4 K (-78.69 %) |
Jun 02 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 5,000 | 36,900 | 6,354 | 1.4 K to 6.4 K (+369.28 %) |
May 31 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 5,000 | 36,900 | 66,750 | |
May 31 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 5,000 | 36,900 | 71,750 | |
May 31 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 31.93 | 5,000 | 159,650 | 1,354 | 6.4 K to 1.4 K (-78.69 %) |
May 31 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 5,000 | 36,900 | 6,354 | 1.4 K to 6.4 K (+369.28 %) |
May 31 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 31.47 | 5,000 | 157,350 | 1,354 | 6.4 K to 1.4 K (-78.69 %) |
May 31 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 5,000 | 36,900 | 6,354 | 1.4 K to 6.4 K (+369.28 %) |
May 26 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 5,000 | 36,900 | 76,750 | |
May 26 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 31.01 | 5,000 | 155,050 | 1,354 | 6.4 K to 1.4 K (-78.69 %) |
May 26 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 5,000 | 36,900 | 6,354 | 1.4 K to 6.4 K (+369.28 %) |
May 25 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 50,000 | 369,000 | 81,750 | |
May 25 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 30.13 | 50,000 | 1,506,415 | 1,354 | 51.4 K to 1.4 K (-97.36 %) |
May 25 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 50,000 | 369,000 | 51,354 | 1.4 K to 51.4 K (+3,692.76 %) |
May 03 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 0.00 | 1,354 | 0 | 4,063 | |
May 03 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 0.00 | 1,354 | 0 | 1,354 | 0 to 1.4 K |
Apr 27 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 0.00 | 4,833 | 0 | 4,833 | |
Apr 27 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 31.49 | 43,500 | 1,369,815 | 43,500 | |
Feb 16 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 10,000 | 73,800 | 131,750 | |
Feb 16 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 25.35 | 10,000 | 253,457 | 0 | 10 K to 0 (-100.00 %) |
Feb 16 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 10,000 | 73,800 | 10,000 | 0 to 10 K |
Feb 15 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 10,000 | 73,800 | 141,750 | |
Feb 15 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 24.53 | 10,000 | 245,344 | 0 | 10 K to 0 (-100.00 %) |
Feb 15 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 10,000 | 73,800 | 10,000 | 0 to 10 K |
Feb 11 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 10,000 | 73,800 | 151,750 | |
Feb 11 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 10,000 | 73,800 | 161,750 | |
Feb 11 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 24.73 | 10,000 | 247,266 | 0 | 10 K to 0 (-100.00 %) |
Feb 11 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 10,000 | 73,800 | 10,000 | 0 to 10 K |
Feb 11 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 24.51 | 10,000 | 245,081 | 0 | 10 K to 0 (-100.00 %) |
Feb 11 2011 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 10,000 | 73,800 | 10,000 | 0 to 10 K |
May 03 2010 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 0.00 | 5,417 | 0 | 5,417 | |
May 03 2010 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 20.47 | 48,750 | 997,913 | 48,750 | |
Apr 27 2010 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 60,000 | 442,800 | 171,750 | |
Apr 27 2010 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 20.00 | 60,000 | 1,200,000 | 0 | 60 K to 0 (-100.00 %) |
Apr 27 2010 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 60,000 | 442,800 | 60,000 | 0 to 60 K |
Oct 15 2009 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 60,000 | 442,800 | 231,750 | |
Oct 15 2009 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 15,000.00 | 60,000 | 900,000,000 | 0 | 60 K to 0 (-100.00 %) |
Oct 15 2009 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 60,000 | 442,800 | 60,000 | 0 to 60 K |
Apr 29 2009 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 8.43 | 65,000 | 547,950 | 65,000 | |
Jul 02 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 1,650 | 12,177 | 291,750 | |
Jul 02 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 27.79 | 1,650 | 45,856 | 0 | 1.7 K to 0 (-100.00 %) |
Jul 02 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 1,650 | 12,177 | 1,650 | 0 to 1.7 K |
Jun 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 1,650 | 12,177 | 293,400 | |
Jun 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 26.38 | 150 | 3,957 | 0 | 150 to 0 (-100.00 %) |
Jun 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 26.36 | 150 | 3,953 | 150 | 300 to 150 (-50.00 %) |
Jun 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 26.24 | 200 | 5,248 | 300 | 500 to 300 (-40.00 %) |
Jun 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 26.20 | 150 | 3,930 | 500 | 650 to 500 (-23.08 %) |
Jun 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 26.17 | 150 | 3,925 | 650 | 800 to 650 (-18.75 %) |
Jun 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 26.15 | 200 | 5,230 | 800 | 1,000 to 800 (-20.00 %) |
Jun 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 26.13 | 150 | 3,920 | 1,000 | 1.2 K to 1,000 (-13.04 %) |
Jun 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 26.11 | 150 | 3,916 | 1,150 | 1.3 K to 1.2 K (-11.54 %) |
Jun 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 26.09 | 350 | 9,130 | 1,300 | 1.7 K to 1.3 K (-21.21 %) |
Jun 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 1,650 | 12,177 | 1,650 | 0 to 1.7 K |
May 05 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 1,650 | 12,177 | 295,050 | |
May 05 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 23.00 | 1,650 | 37,950 | 0 | 1.7 K to 0 (-100.00 %) |
May 05 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 1,650 | 12,177 | 1,650 | 0 to 1.7 K |
Apr 25 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 19.85 | 75,000 | 1,488,750 | 75,000 | |
Apr 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 1,650 | 12,177 | 296,700 | |
Apr 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | S | 24.40 | 200 | 4,880 | 0 | -200 to 0 (-100.00 %) |
Apr 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | S | 24.29 | 50 | 1,215 | 200 | 150 to 200 (+33.33 %) |
Apr 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | S | 24.28 | 200 | 4,856 | 250 | 50 to 250 (+400.00 %) |
Apr 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | S | 24.15 | 200 | 4,830 | 450 | 250 to 450 (+80.00 %) |
Apr 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | S | 24.10 | 200 | 4,820 | 650 | 450 to 650 (+44.44 %) |
Apr 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | S | 24.08 | 200 | 4,816 | 850 | 650 to 850 (+30.77 %) |
Apr 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | S | 24.07 | 200 | 4,814 | 1,050 | 850 to 1.1 K (+23.53 %) |
Apr 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | S | 24.04 | 100 | 2,404 | 1,250 | 1.2 K to 1.3 K (+8.70 %) |
Apr 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | S | 24.00 | 200 | 4,800 | 1,350 | 1.2 K to 1.4 K (+17.39 %) |
Apr 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 23.97 | 100 | 2,397 | 1,550 | 1.7 K to 1.6 K (-6.06 %) |
Apr 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 1,650 | 12,177 | 1,650 | 0 to 1.7 K |
Mar 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | M | 7.38 | 1,650 | 12,177 | 298,350 | |
Mar 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Sell | S | 26.00 | 1,650 | 42,901 | 0 | 1.7 K to 0 (-100.00 %) |
Mar 03 2008 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Buy | M | 7.38 | 1,650 | 12,177 | 1,650 | 0 to 1.7 K |
Apr 27 2007 | CPHD | CEPHEID | PERSING DAVID H | Exec VP,Chief Med/T ... | Option Exercise | A | 11.94 | 60,000 | 716,400 | 60,000 | |
May 03 2004 | CPHD | CEPHEID | PERSING DAVID H | Director | Option Exercise | A | 7.35 | 15,000 | 110,250 | 15,000 |